| abstract |
The invention relates to the use of extracts containing phytoestrogen, which exhibit a selective modulating effect of the beta estrogen receptor without producing a uterotropic reaction. In the treatment of clinical conditions and pathophysiological conditions that are selected from the group covered: obesity and possible influences of metabolic syndrome, in particular hypertonia, arteriosclerosis, heart attacks, hyperandrogenemia, menopause incontinence problems; hot flashes of menopause associated with the hyperstimulation of the hypothalamus hormonal pulse generator that releases gonadotropin; steroid hormone synthesis disorder, in particular the progesterone synthesis of the human luteo body as a cause of luteinic insufficiency; Alzheimer's disease that is associated with increased expression of the beta estrogen receptor in hippocampal neurons. |